WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- BVI, a diversified global ophthalmic device company, today announced certification for its…
EBT-101 is an in vivo CRISPR-based therapeutic designed to remove HIV proviral DNA from affected cell reservoirs First-in-human study will…
TNX-1500 Treatment Prevents Organ Rejection and Preserves Function for Both Allograft and Xenograft Transplants in Animal Studies CHATHAM, N.J., Sept.…
FARMINGTON HILLS, Mich., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused…
TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SLHG) (“Skylight Health” or the “Company”), a healthcare platform…
New Limited-Edition Infused Pre-Rolls Now Available Across Ontario, CanadaTORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or…
- Prestigious ALS Association grant awarded to BWH to study the utility of an intranasal anti-CD3 monoclonal antibody in an…
Results from Largest Ever Real-World Evaluation of the MANTA® Device Demonstrated Safety and Effectiveness with Low Complication Rates and a…
BERLIN, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Forever Healthy Foundation is pleased to announce the Rejuvenation Startup Summit 2022…
The first shipment of the new products has been received and online sales will resumeLOS ANGELES, Sept. 15, 2022 (GLOBE…